Primary Site >> Liver Cancer

Gene >> TYR

  • 1988
  • 1991
  • 1992
  • 1995
  • 1996
  • 1998
  • 1999
  • 2000
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide.
PMID: 2449438
Ref: Interleukin-1 represents a new modality for the activation of extracellular signal-regulated kinases/microtubule-associated protein-2 kinases.
PMID: 1658005
Ref: [Nutritional treatment of hepatocellular carcinoma].
PMID: 1580635
Ref: Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.
PMID: 7562058
Ref: Serum amino acid disturbance in multiple myeloma with hyperammonemia.
PMID: 7599324
Ref: Association of inhibition of cell growth by O-phospho-L-tyrosine with decreased tyrosine phosphorylation.
PMID: 8603380
Ref: Biochemical characterization of alpha-fetoprotein and other serum proteins produced by a uterine endometrial adenocarcinoma.
PMID: 8766525
Ref: Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility.
PMID: 10026993
Ref: Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma.
PMID: 10339662
Ref: Interaction between haemochromatosis and transferrin receptor genes in hepatocellular carcinoma.
PMID: 11096344
Ref: Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.
PMID: 11209059
Ref: Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
PMID: 11216533
Ref: In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial.
PMID: 11965610
Ref: Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
PMID: 12171531
Ref: Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.
PMID: 14499161
Ref: TT-232: a somatostatin structural derivative as a potent antitumor drug candidate.
PMID: 14501379
Ref: Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma.
PMID: 14571716
Ref: The synthesis, distribution, and anti-hepatic cancer activity of YSL.
PMID: 15336278
Ref: (99m)Tc-labeled [N4(0),Pro(1),Tyr(4)]bombesin
PMID: 20641306
Ref: Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
PMID: 15869461
Ref: Somatostatin receptor subtype 2-mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in human hepatocellular carcinoma-bearing nude mice.
PMID: 15991301
Ref: STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.
PMID: 16285960
Ref: Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma.
PMID: 16935383
Ref: Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery.
PMID: 17102938
Ref: Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
PMID: 17475221
Ref: Animal models of tyrosinemia.
PMID: 17513424
Ref: Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer.
PMID: 17604334
Ref: Involvement of the role of Chk1 in lithium-induced G2/M phase cell cycle arrest in hepatocellular carcinoma cells.
PMID: 18247328
Ref: Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cells.
PMID: 18752886
Ref: Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
PMID: 18829493
Ref: Intraindividual comparison of selective arterial versus venous 68Ga-DOTATOC PET/CT in patients with gastroenteropancreatic neuroendocrine tumors.
PMID: 20460485
Ref: p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.
PMID: 21452288
Ref: Iodine 125-labeled mesenchymal-epithelial transition factor binding peptide-click-cRGDyk heterodimer for glioma imaging.
PMID: 21575108
Ref: Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cells.
PMID: 21624128
Ref: c-Met-Akt pathway-mediated enhancement of inhibitory c-Raf phosphorylation is involved in vitamin K1 and sorafenib synergy on HCC growth inhibition.
PMID: 21734462
Ref: Kit for preparation of multimeric receptor-specific (9)(9)mTc-radiopharmaceuticals based on gold nanoparticles.
PMID: 21860334
Ref: Targeting of hepatocellular carcinoma with glypican-3-targeting peptide ligand.
PMID: 21976137
Ref: A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.
PMID: 22465052
Ref: Microsomal Epoxide Hydrolase Polymorphisms and Haplotypes as Determinants of Hepatitis B Virusand Hepatitis C Virus-related Liver Disease in Indian Population.
PMID: 25755418
Ref: Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
PMID: 23032719
Ref: Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma.
PMID: 23281009
Ref: Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-alpha2a for liver cancer therapy.
PMID: 23328125
Ref: Phosphorylation of cMet tyrosine residues in murine ascitic hepatic cancer cell lines with different lymph node metastatic potentials.
PMID: 23778885
Ref: Peptide-biphenyl hybrid-capped AuNPs: stability and biocompatibility under cell culture conditions.
PMID: 23829784
Ref: Hellebrigenin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt.
PMID: 24954031
Ref: Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice.
PMID: 25081276
Ref: Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo.
PMID: 25320076
Ref: SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors.
PMID: 25319765
Ref: Structural features of interfacial tyrosine residue in ROBO1 fibronectin domain-antibody complex: Crystallographic, thermodynamic, and molecular dynamic analyses.
PMID: 25492858
Ref: SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
PMID: 25619838
Ref: Neurotensin receptors in pancreatic ductal carcinomas.
PMID: 25859423
Ref: HIF-2alpha regulates CDCP1 to promote PKCdelta-mediated migration in hepatocellular carcinoma.
PMID: 26307391
Ref: Adamantyl-tethered-biphenylic compounds induce apoptosis in cancer cells by targeting Bcl homologs.
PMID: 26725030
Ref: Early Dynamic 68Ga-DOTA-D-Phe1-Tyr3-Octreotide PET/CT in Patients With Hepatic Metastases of Neuroendocrine Tumors.
PMID: 26859210
Ref: A new cyclic RGD peptide dimer for integrin alphavbeta3 imaging.
PMID: 26957261
Ref: Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma.
PMID: 27397503
Ref: Sinularin induces DNA damage, G2/M phase arrest, and apoptosis in human hepatocellular carcinoma cells.
PMID: 28103869
Ref: Synthesis, Cytotoxicity And Antioxidant Activity Of New Analogues Of Rc-121 Synthetic Derivatives Of Somatostatin.
PMID: 29667555
Ref: Tandem Enzymatic Self-Assembly and Slow Release of Dexamethasone Enhances Its Antihepatic Fibrosis Effect.
PMID: 30285414